Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Advanced Gastric Cancer
Interventions: Procedure: laparoscopy assisted distal gastrectomy; Procedure: open distal gastrectomy
Sponsor: National Cancer Center, Korea
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Condition: Colorectal Neoplasms
Interventions: Drug: Glutamine; Drug: Calcium and Magnesium
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Hepatocellular Carcinoma
Intervention: Drug: Adjuvant group
Sponsor: Yonsei University
Completed - verified January 2009
Conditions: Bladder Cancer; Cervical Cancer; Colorectal Cancer; Endometrial Cancer; Gastrointestinal Complications; Long-term Effects Secondary to Cancer Therapy in Adults; Ovarian Cancer; Prostate Cancer; Radiation Toxicity; Sarcoma; Testicular Germ Cell Tumor; Vaginal Cancer
Interventions: Other: questionnaire administration; Procedure: gastrointestinal complications management/prevention; Procedure: quality-of-life assessment
Sponsor: Royal Marsden NHS Foundation Trust
Recruiting - verified March 2010
Conditions: Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms
Intervention: Behavioral: Psychosocial rehabilitation course
Sponsors: Danish Cancer Society; University Hospital Århus, Department of Surgery; University Hospital Århus, Urology Department; Regional Hospital Randers, Department of Colorectal Surgery; Regional Hospital Hørsholm, Department of Breast Surgery
Completed - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: systemic chemotherapy; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Procedure: therapeutic conventional surgery
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: BMS-908662; Drug: BMS-908662; Drug: Cetuximab
Sponsors: Bristol-Myers Squibb; Genzyme
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer Screening
Intervention: Behavioral: Tailored interactive intervention to increasing CRCS
Sponsors: The University of Texas Health Science Center, Houston; National Cancer Institute (NCI)
Completed - verified March 2010
Condition: Pancreatic Neoplasms
Intervention: Drug: Nelfinavir
Sponsors: University of Iowa; Holden Comprehensive Cancer Center
Recruiting - verified March 2010
Condition: Colorectal Neoplasms
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Conditions: Advanced Gastric Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: AUY922; Drug: Docetaxel or Irinotecan
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Mek Inhibitor MSC1936369B; Drug: Mek Inhibitor MSC1936369B; Drug: Placebo; Drug: FOLFIRI
Sponsor: EMD Serono
Recruiting - verified March 2010
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Gemcitabine, nab-Paclitaxel, GDC-0449
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Stand Up To Cancer; Genentech; Abraxis BioScience Inc.
Not yet recruiting - verified March 2010
Condition: Colorectal Neoplasms
Intervention: Drug: Erbitux (Cetuximab)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Liver Cancer
Interventions: Drug: iodinated contrast dye; Drug: motexafin gadolinium; Other: laboratory biomarker analysis
Sponsors: American College of Radiology Imaging Network; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Conditions: Liver Fibrosis; Liver Cirrhosis; Viral Hepatitis; Liver Tumour; Cardiac Failure; Biliary Cholestasis.
Interventions: Device: ARFI measurement; Device: ARFI measurement; Device: ARFI measurement
Sponsor: University Hospital, Bordeaux
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Biological: ramucirumab; Drug: irinotecan hydrochloride
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Conditions: Length of Stay; Complications; Adverse Drug Event; Quality of Life; Hospital Costs
Interventions: Procedure: Laparoscopic Surgery for Colorectal Cancer; Drug: XELOX Chemotherapy; Drug: mFolfox6 chemotherapy; Other: Fast Track Perioperative Treatment; Other: Conventional Perioperative Treatment; Procedure: Open Surgery for Colorectal Cancer
Sponsor: Zhejiang University
Not yet recruiting - verified March 2010
Conditions: Cognitive/Functional Effects; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: systemic chemotherapy; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: cognitive assessment; Procedure: quality-of-life assessment
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Pancreatic Cancer
Intervention: Drug: Gemcitabine and Pazopanib
Sponsor: Washington University School of Medicine
Not yet recruiting - verified March 2010
Condition: Liver Cancer
Interventions: Drug: temsirolimus; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: quality-of-life assessment; Radiation: fludeoxyglucose F 18
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified March 2010
Condition: Hepatocellular Cancer
Intervention:
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Condition: Pancreatic Cancer
Intervention: Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting - verified March 2010
Condition: Colorectal Neoplasms
Interventions: Behavioral: Stepped CRCS Interventions; Behavioral: Control
Sponsors: The University of Texas Health Science Center, Houston; Duke University; Boston University
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: capecitabine [Xeloda]; Drug: oxaliplatin
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Condition: Esophageal Cancer
Intervention:
Sponsors: Merck; World Health Information Science Consultants, LLC
Active, not recruiting - verified February 2010
Conditions: Squamous Cell Carcinoma; Adenocarcinoma; Esophageal Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: carboplatin; Drug: Paclitaxel; Drug: Panitumumab; Radiation: 3-D conformal radiation
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified July 2009
Condition: Colorectal Cancer
Intervention:
Sponsors: Newcastle University; Northumbria Healthcare NHS Foundation Trust
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Procedure: Immunochemical fecal occult blood test And colonoscopy if test is positive; Procedure: Colonoscopy with sedation
Sponsor: Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Recruiting - verified September 2008
Condition: Carcinoma, Hepatocellular
Intervention: Device: Ablation with the NanoKnife Irreversible Electroporation (IRE) System
Sponsor: Angiodynamics, Inc.
Recruiting - verified March 2010
Conditions: Head and Neck Cancer; Lung Cancer; Liver Cancer; Rectal Cancer; Cervical Cancer
Intervention: Drug: [F 18]HX4
Sponsor: Siemens Molecular Imaging
Recruiting - verified February 2010
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Capecitabine; Drug: Cetuximab; Drug: Everolimus
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified October 2009
Conditions: Hepatic Metastases; Colorectal Cancer
Intervention: Procedure: Routine hilar lymphadenectomy
Sponsor: University of Heidelberg
Enrolling by invitation - verified February 2010
Conditions: Metastatic Renal Cell Carcinoma; Gastrointestinal Stromal Tumors
Intervention: Drug: Sunitinib malate
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Colorectal Neoplasm
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Conditions: Stage IV Colorectal Cancer; Dignity Therapy
Intervention: Behavioral: Dignity Therapy
Sponsor: Northwestern University
Not yet recruiting - verified February 2010
Condition: Colorectal Cancer
Intervention: Dietary Supplement: vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units)
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified February 2010
Condition: Liver Cancer
Intervention: Device: Theraspheres
Sponsors: Stanford University; MDS Nordion, Inc.
Available - verified February 2010
Condition: Liver Cancer
Interventions: Drug: pravastatin; Drug: sorafenib tosylate; Other: laboratory biomarker analysis; Other: pharmacogenomic studies; Procedure: quality-of-life assessment
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified February 2010
Condition: Advanced Pancreatic Cancer
Intervention:
Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Not yet recruiting - verified February 2010
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Genetic: gene expression analysis; Genetic: polymorphism analysis; Genetic: protein expression analysis; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Biological: pegfilgrastim; Drug: bortezomib; Drug: carboplatin; Other: pharmacological study
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Condition: Enteritis
Intervention: Drug: DOR201 (delayed release beclomethasone dipropionate)
Sponsors: Soligenix; National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Behavioral: Multimedia Education; Behavioral: Print Media; Behavioral: Usual and customary waiting room process
Sponsors: Saint Francis Care; American Cancer Society; Feinberg School of Medicine, Northwestern University
Recruiting - verified February 2010
Condition: Metastatic Colorectal Cancer
Interventions: Drug: ARQ 197 + cetuximab + irinotecan; Drug: Placebo + cetuximab + irinotecan
Sponsor: Daiichi Sankyo Inc.
Recruiting - verified February 2010
Condition: Liver Cancer
Interventions: Drug: sorafenib tosylate; Drug: vorinostat
Sponsors: Virginia Commonwealth University; Massey Cancer Center
Not yet recruiting - verified March 2010
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute-Pancreatic Cancer Vaccine
Sponsor: NewLink Genetics Corporation
Not yet recruiting - verified February 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
